4//SEC Filing
Reich Samuel J 4
Accession 0001437749-23-005165
CIK 0001833214other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 9:18 AM ET
Size
8.1 KB
Accession
0001437749-23-005165
Insider Transaction Report
Form 4
Reich Samuel J
DirectorCEO & EXECUTIVE CHAIRMAN
Transactions
- Other
Warrants
2023-02-28−208,600→ 0 total(indirect: By LLC)Exercise: $11.50From: 2022-01-14Exp: 2026-10-20→ Common Stock (208,600 underlying) - Other
Warrants
2023-02-28+9,968→ 9,968 totalExercise: $11.50From: 2022-01-14Exp: 2026-10-20→ Common Stock (9,968 underlying)
Footnotes (2)
- [F1]Pro rata distribution by Big Cypress Holdings LLC to its members for which no consideration is being paid in connection with such distribution. The Reporting Person is a managing member of Big Cypress Holdings LLC, and as part of the distribution received 9,968 warrants of the issuer, which the Reporting Person previously had an indirect pecuniary interest.
- [F2]The Reporting Person received 9,968 warrants as part of the distribution, which the Reporting Person previously had an indirect pecuniary interest. Therefore, the transaction, which only changes the form of the Reporting Person's ownership without increasing or decreasing his pecuniary interest, is exempt from the reporting requirements of Section 16 pursuant to Rule 16a-13. Notwithstanding, the Reporting Person is reporting the acquisition on a voluntary basis.
Documents
Issuer
SAB Biotherapeutics, Inc.
CIK 0001833214
Entity typeother
Related Parties
1- filerCIK 0001394645
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 9:18 AM ET
- Size
- 8.1 KB